Randgold Resources: Directorate Change

JERSEY, CHANNEL ISLANDS -- (Marketwired) -- 02/05/16 -- Randgold Resources (LSE: RRS) (NASDAQ: GOLD)

RANDGOLD RESOURCES LIMITED Incorporated in Jersey, Channel Islands Reg. No. 62686 LSE Trading Symbol: RRS NASDAQ Trading Symbol: GOLD ("Randgold Resources" or the "Company")

CHANGES TO THE BOARD: RETIREMENT OF A NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF A NEW MEMBER OF THE AUDIT COMMITTEE

Kibali, DRC, 5 February 2016 - Randgold Resources announces that as he has come to the end of his term of service and as set out in its Annual Report 2014, Karl Voltaire, a non-executive director since 2006 and a member of the Company's audit and remuneration committees, will retire from the board at the Company's next annual general meeting to be held on 3 May 2016.

Also Randgold Resources announces that Safiatou Ba-N'Daw, a non-executive director, has been appointed a member of the audit committee with effect from 2 May 2016.

Commenting on the changes to the board's composition Randgold Resources' Chairman, Christopher Coleman, said: "Karl has made a major contribution to the Company over the last 10 years as a non-executive director which has been a very successful period in the Company's history. On behalf of the board I would like to thank Karl for all his hard work and support which he has shown me in my time as chairman. "

RANDGOLD RESOURCES ENQUIRIES:

                                                  Investor & Media
Chief Executive          Financial Director       Relations
Mark Bristow             Graham Shuttleworth      Kathy du Plessis
+44 788 071 1386         +44 1534 735 333         +44 20 7557 7738
+44 779 775 2288         +44 779 771 1338         Email: [email protected]

Website: www.randgoldresources.com

Contact:
RNS
Customer Services
0044-207797-4400
[email protected]
http://www.rns.com

Source: Randgold Resources

You May Also Be Interested In

• MidFirst Bank’s 1st Century Division Donates $250,000 to Saint John’s Health Center
• Interius BioTherapeutics to Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene and Cell Therapy 27th Annual Meeting
• DigiKey to Showcase Full Automation Offerings and Value-Add Services at Automate 2024